Hansenulapolymorpha

· National Vaccine and Serum Institute, China

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for Hansenulapolymorpha, covering 2022-05-06 to 2026-01-23. Get the full timeline:

Most recent: Clinical Trial Update: Phase IIIb Clinical Trial of Quadrivalent Recombinant Human Papillomavirus Vaccine (Hansenulapolymorpha) for Age/Immunization Schedule Bridging [Phase 3]

See pricing